SCHEMBL1224802

SCHEMBL1224802

COc1c[c]ccc1OCc1ccncc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLK1 P53350 1/20 0.47
LMNA P02545 2/20 0.42
KDM4E B2RXH2 1/20 0.42
USP2 O75604 1/20 0.42
ALDH1A1 P00352 1/20 0.42
TSHR P16473 1/20 0.42
HSD17B10 Q99714 1/20 0.42
ABCB1 P08183 2/20 0.41
APP P05067 1/20 0.41
ERBB2 P04626 1/20 0.37
EPHA2 P29317 1/20 0.37
KDR P35968 1/20 0.37
RXRA P19793 1/20 0.37
HTR1A P08908 1/20 0.37
ADRA1D P25100 1/20 0.37
ADRA1A P35348 1/20 0.37
ADRA1B P35368 1/20 0.37
GAA P10253 1/20 0.37
CSF1R P07333 2/20 0.37
SLC6A4 P31645 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL339374 0.84 HTR1A (0.53) KDM4EABCB1APPRXRAHTR1A
SCHEMBL1224868 0.82 LMNA (0.50) LMNAKDM4EALDH1A1HSD17B10EPHA2
SCHEMBL18707424 0.81 APP (0.47) LMNAKDM4EALDH1A1APPRXRA
SCHEMBL3138119 0.81 RAB9A (0.54) PLK1LMNAKDM4EALDH1A1TSHR
SCHEMBL28335845 0.81 MAOB (0.43) APPCSF1RSLC6A4NTRK1NTRK2
SCHEMBL693903 0.79 SCD (0.41) PLK1LMNAKDM4EALDH1A1ABCB1
SCHEMBL18707175 0.79 RAB9A (0.45) TSHRAPPRXRANPSR1NPC1
SCHEMBL11959691 0.78 APP (0.64) PLK1LMNAKDM4EUSP2ALDH1A1
SCHEMBL1225065 0.78 SYK (0.42) KDM4EALDH1A1GAANPC1RAB9A
SCHEMBL182637 0.78 HTR1A (0.53) LMNAKDM4EALDH1A1HSD17B10ABCB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110033393-A1 Hydrazone Compounds and Their Use REDPOINT BIO CORPORATION 2011-02-10 US disclosed
WO-2010132615-A1 HYDRAZONE COMPOUNDS AND THEIR USE STEIN PHILIP (US) 2010-11-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110033393-A1 Hydrazone Compounds and Their Use TRPM5, TRPV5, TRPM8 PLK1 1281/4885LMNA 2883/4885KDM4E 2023/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.